Olanzapine represents a second-generation atypical antipsychotic agent approved for the treatment of psychotic disorders, schizophrenia, schizoaffective disorders, mania and other conditions with psychotic components. As the usage of such atypical antipsychotic medications in adults and children increases, the number of overdoses and unintentional ingestions will continue to grow. The adverse consequences of olanzapine overdose are […]